2022 (remaining three months) 2022 (from April to December) Lessee, Operating Lease, Liability, to be Paid, Year One Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Document Transition Report Document Transition Report Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (in years) Money market funds Money market funds Money Market Funds [Member] Recently Adopted Accounting Pronouncements Recently Adopted Accounting Pronouncements Policy [Text Block] Recently adopted accounting pronouncements policy text block Stock issuance costs Payments of Stock Issuance Costs Shares issuable pursuant to the ESPP Shares issuable pursuant to the ESPP. Shares Issuable Pursuant To The ESPP [Member] Shares Issuable Pursuant To The ESPP [Member] Warrants Not Settleable in Cash, Fair Value Disclosure Summary of the Changes in the Fair Value of the Company’s Liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Marketable Securities Estimated Fair Value Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Summary of Consolidated Balance Sheets and Statements of Cash Flow related to Leases Condensed Financial Statements [Table Text Block] Receivables, Long-Term Contracts or Programs Receivables, Long-term Contracts or Programs, Total Receivables or net contract assets from agreement Exchange of Class A Units of Rani LLC from the Former LLC Owners Exchange of Class A Units of Rani LLC from the Former LLC Owners Exchange of Class A Units of Rani LLC from the Former LLC Owners Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Restricted stock units Restricted Stock Units [Member] Restricted Stock Units (RSUs) [Member] Level 1 Fair Value, Inputs, Level 1 [Member] Issuance of Series E preferred units Temporary Equity, Stock Issued During Period, Value, New Issues Marketable securities Available-for-Sale Securities [Member] Weighted Average Weighted Average [Member] Document Information [Table] Fair Value Measurements Fair Value Disclosures [Text Block] Contract revenue Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer, Excluding Assessed Tax, Total Remaining principal amount Remaining principal amount Short-Term Debt, Type [Axis] Rani Management Service and In Cube Labs LLC [Member] Rani Management Service and In Cube Labs LLC [Member] RMS-ICL Line of credit available to be drawn Line Of Credit Available To be Drawn Line Of Credit Available To be Drawn Equity-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Weighted-average discount rate Operating and Finance Lease, Weighted Average Discount Rate, Percent Weighted average discount rate for operating and finance leases calculated at point in time. Subsequent Events [Text Block] Subsequent Events Schedule of Assets and Liabilities Recorded at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Non-corresponding Class A Units Non Corresponding Class A Units [Member] Non Corresponding Class A Units [Member] Non Corresponding Class A Units [Member] Operating lease liability, less current portion Operating Lease, Liability, Noncurrent, Total Operating lease liability, less current portion Operating Lease, Liability, Noncurrent Net loss attributable to non-controlling interest Net Income (Loss) Attributable to Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest, Total Net loss attributable to non-controlling interest Loan Restructuring Modification Name [Domain] Financial liabilities measured at fair value Liabilities, Fair Value Disclosure Total liabilities Liabilities, Fair Value Disclosure, Total Assets: Assets, Fair Value Disclosure [Abstract] Common Unit Authorized Common units, authorized Common Unit, Authorized Related Party Transactions [Abstract] Balance Sheet Location [Axis] Total current assets Assets, Current Vesting [Domain] Total liabilities and stockholders' equity Liabilities and Equity Entity Address, State or Province Entity Address, State or Province Issuance of Class A common stock in connection with the IPO, net of issuance costs, shares Issuance of Class A common stock in connection with the IPO, net of issuance costs, shares Long-Term Debt Long-Term Debt with Detachable Warrants Long-Term Debt [Text Block] Issuance of Class A common stock in connection with the IPO, net of issuance costs , amount Stock Issued During Period, Value, New Issues Number of Options, Outstanding, Beginning balance Number of Options, Outstanding, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Stock options, outstanding Comprehensive loss attributable to Rani Therapeutics Holdings, Inc. Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Series e warrants member. Series E Warrants [Member] Series E Warrants Weighted Average Exercise Price per Share, Granted as replacement awards Share Based Compensation Arrangements By Share Based Payment Award Options Grants As Replacement Awards In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Options Grants As Replacement Awards In Period Weighted Average Exercise Price Trading Symbol Trading Symbol Deferred tax asset Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance, Total Common stock shares issued Common Stock, Shares, Issued Common Stock, Shares, Issued, Total Common stock units issued Long-Term Debt, Maturity, Year Two 2025 Class A unit Member Capital Unit, Class A [Member] Effects of organizational transactions. Effects of Organizational Transactions Consolidated Entities Consolidated Entities [Domain] Cash Equivalents [Member] Cash and Cash Equivalents [Member] Increase (Decrease) in Accounts Payable, Trade Accounts payable Accounts payable Market capitalization. Market Capitalization Market capitalization Schedule of Long-Term Debt Instruments [Table] Unaudited Interim Condensed Consolidated Financial Statements Unaudited Interim Financial Information Policy [Text Block] Unaudited interim financial information. Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Common units reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Shares reserved for future issuance Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax, Total Entity Address, City or Town Entity Address, City or Town Related Party Transaction [Line Items] Related Party Transaction [Line Items] 2023 (remaining six months) Long-Term Debt, Maturity, Remainder of Fiscal Year Common unit conversion basis Common Stock, Conversion Basis Common stock, conversion basis Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Non-controlling Interest Non-controlling Interests Policy Text Block Non-controlling Interests Policy Text Block Subsequent Event [Member] Subsequent Event Subsequent Event Type Subsequent Event Type [Axis] Finance Lease, Principal Payments Aggregate principal amount Share-Based Payment Arrangement, Tranche Two [Member] Tranches Two Percentage of tax benefit to be transferred Percentage Of Tax Benefit To Be Transferred Percentage of tax benefit to be transferred. Additional Paid in Capital [Member] Additional Paid-in Capital [Member] Measurement Input, Discount for Lack of Marketability Measurement Input, Discount for Lack of Marketability [Member] Current liabilities: Liabilities, Current [Abstract] Current assets: Assets, Current [Abstract] Preferred Stock, Par or Stated Value Per Share Preferred stock, par or stated value per share Preferred stock, par value Statement of Stockholders' Equity [Abstract] Operating lease liability, current portion Less: Operating lease liability, current portion Operating Lease, Liability, Current Marketable Securities, Policy [Policy Text Block] Marketable Securities Revenue from Contract with Customer, Including Assessed Tax Revenue from contract Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Summary of Significant Unobservable Inputs used in the Fair Value Measurement of the Series E Preferred Unit Warrant Liability Summary of Significant Unobservable Inputs used in the Fair Value Measurement of the Series E Preferred Unit Warrant Liability Debt Instrument, Maturity Date Debt Instrument Maturity Date Total principal payments Long-Term Debt Property and equipment, net Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Total Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Class of Stock Class of Stock [Domain] Cash Flows Additional Cash Flow Elements [Abstract] Restricted cash equivalents Restricted Cash Equivalents Restricted Cash Equivalents, Total One time patent payment to related party One time patent payment to related party Statement of Comprehensive Income [Abstract] Measurement Input Probability Of Exit Events Measurement Input Probability Of Exit Events [Member] Measurement input probability of exit events member. Scenario [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Component of prepaid expenses Increase (Decrease) in Prepaid Expenses, Other Entity Central Index Key Entity Central Index Key Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Forfeiture of restricted stock awards Securities purchase in exchange for warrant Class of Warrant or Right, Number of Securities Called by Warrants or Rights Plan Name Plan Name [Domain] Evaluation Agreements [Abstract] evaluation agreements abstract. Rani LLC-ICL Service Agreement [Member] Rani LLC-ICL Service Agreement [Member] Fair value measurement discount for lack of marketability Fair Value Measurement Discount For Lack Of Marketability Fair value measurement discount for lack of marketability. Total assets Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total RMS-ICL Service Agreement [Member] RMS-ICL Service Agreement [Member] Preferred stock outstanding Units Outstanding Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Total current liabilities Liabilities, Current Entity Tax Identification Number Entity Tax Identification Number Upfront payment Upfront Payment upfront payment. Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Line of Credit Facility, Description Line of Credit Facility, Description Financial Instruments [Domain] Share Based Compensation Profit Interests Granted Weighted Average Grant Date Fair Value Share based compensation profit interests granted weighted average grant date fair value. Weighted Average Grant Date Fair Value, Granted Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Award Type Award Type [Axis] Granted as replacement of Profits Interests, Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants As Replacement Of Profits Interests In Period Share based compensation arrangement by share based payment award equity instruments other than options grants as replacement of profits interests in period. Preferred Units by Name Preferred Units by Name [Axis] Leases Lessee, Operating Leases [Text Block] Restricted Stock Awards Restricted Stock Restricted Stock [Member] Cash and Cash Equivalents [Abstract] Class of Warrant or Right [Line Items] Plan Name Plan Name [Axis] Fair value measurement expected volatility rate Fair Value Measurement Expected Volatility Rate Fair value measurement expected volatility rate. Total assets Assets Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Unrecognized equity-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Common Class A [Member] Common Class A Common Class A [Member] Entity Registrant Name Entity Registrant Name Lessee, Lease, Description [Line Items] Related Party Related Party, Type [Domain] Deferred financing costs included in accrued expenses Deferred Financing Costs Included In Accrued Expenses Deferred financing costs included in accrued expenses. Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Proceeds from Stock Plans Proceeds from employee stock purchase plan Members Deficit [Member] Accumulated Deficit [Member] Retained Earnings [Member] Class of Stock Class of Stock [Axis] Outstanding, Number of Shares, Ending Balance Outstanding, Number of Shares, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Beginning Balance Total stockholders' equity Ending Balance Equity, Including Portion Attributable to Noncontrolling Interest Issuance of common stock under employee stock purchase plan (Shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Minimum Minimum [Member] Minimum Significant Accounting Policies Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Lease liability Total operating lease liability Operating Lease, Liability Forecast [Member] Liabilities: Liabilities, Fair Value Disclosure [Abstract] Share-Based Payment Arrangement, Tranche One [Member] Tranches One Revenue Recognition Revenue [Policy Text Block] Income tax payable, amount Accrued Income Taxes, Current Accrued Taxes Capital Unit, Class [Domain] Equity Component Equity Component [Domain] Summary of cash, cash equivalents, restricted cash equivalents and marketable securities Cash, Cash Equivalents and Investments [Table Text Block] Conversion of stock, shares Conversion of Stock, Shares Converted Significant Accounting Policies Significant accounting policies. Significant Accounting Policies [Policy Text Block] Amortization of debt discount and issuance costs Amortization of Debt Issuance Costs and Discounts Amortization of Debt Issuance Costs and Discounts, Total Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Less: amount representing debt discount Less: amount representing debt discount Debt Instrument, Unamortized Discount (Premium), Net Measurement Frequency Measurement Frequency [Axis] Debt Disclosure [Abstract] Entity Current Reporting Status Entity Current Reporting Status Common stock shares authorized Common Stock, Shares Authorized Research and development Research and Development Expense Research and Development Expense, Total Cash and Cash Equivalents [Line Items] Long-Term Debt with Detachable Warrants Debt, Policy [Policy Text Block] Corporate debt securities Debt Security, Corporate, US [Member] Effect of exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC Exchanges of non-corresponding Class A Units of Rani LLC Exchange of common units. Exchange Of Common Units Series b warrants member. Series B Warrants [Member] Series B Warrants Assets: Assets [Abstract] Exchange of shares issued Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Non-controlling interest adjustment for changes in proportionate ownership in Rani LLC Stock Issued During Period, Value, Conversion of Units Measurement Input, Expected Term Measurement Input, Expected Term [Member] Convertible Preferred [Member] Convertible Preferred Stock [Member] Convertible Preferred Units Common stock, value Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Common stock units issued Adjustment of tax benefit Beneficial Interest Liability Current Fiscal Year End Date Current Fiscal Year End Date Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation expense Share Based Compensation Number Of Profits Interests Vested Share based compensation number of profits interests vested. Number of Profit Interests Vested Weighted average number Of shares outstanding basic and diluted Weighted Average Number Of Shares Outstanding Basic and Diluted Denominator: Change in uncertain tax position Unrecognized Tax Benefits, Period Increase (Decrease) Unrecognized Tax Benefits, Period Increase (Decrease), Total Loss from operations Operating Income (Loss) Entity Ex Transition Period Entity Ex Transition Period Income tax expense Income tax expense Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Deferred Offering Costs Deferred offering costs Research and Development Expense Research and Development Expense [Member] Research and Development 2026 Long-Term Debt, Maturity, Year Four Leases Lessee, Leases [Policy Text Block] Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Share-Based Payment Arrangement, Expense Total equity-based compensation Stock-based compensation expense Tax withholdings paid on behalf of employees for net share settlement Payment, Tax Withholding, Share-Based Payment Arrangement Measurement Input Type Measurement Input Type [Domain] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Operating lease liabilities Adoption of Accounting Standards Update 2016-02 [Member] Accounting Standards Update 2016-02 [Member] Exchange of paired interests Exchange of Paired Interest Exchange of paired interest. Deferred revenue Balance at beginning of period Balance at end of period Deferred Revenue Deferred Revenue, Total Profits Interests Threshold, Canceled and replaced with restricted stock awards Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Canceled and replaced with Restricted Stock Awards Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Canceled and replaced with Restricted Stock Awards. Aggregate Intrinsic Value, Outstanding, Beginning Balance Aggregate Intrinsic Value, Outstanding, Ending Balance Aggregate Intrinsic Value, Exercisable at September 30, 2021 (in thousands) Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Debt instrument face amount Debt Instrument, Face Amount Net Loss Per Class A Common Share Attributable to Rani Holdings Net Loss Per Class A Common Share Attributable to Rani Therapeutics Holdings, Inc. Earnings Per Share, Policy [Policy Text Block] Parent Company [Member] Rani Therapeutics Holdings Inc. [Member] Common unit, price per share Sale of Stock, Price Per Share Stock offering price per share Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Comprehensive loss attributable to non-controlling interest Comprehensive loss attributable to non-controlling interest Comprehensive loss attributable to non-controlling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total Operating expenses Operating Expenses [Abstract] Uncalled amount of debt UNCALLED AMOUNT OF DEBT UNCALLED AMOUNT OF DEBT Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Tax Receivable Agreement [Member] Tax Receivable Agreement [Member] Subsequent Events [Abstract] Profits Interests Threshold, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Forfeitures Profits Interests Activity Threshold Forfeitures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance Nonvested at June 30, 2022 Commitments and Contingencies Disclosure [Abstract] Number of Options, Unit Grants Number of Options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Equity [Text Block] Stockholders' Equity Issuance costs included in accrued expenses Issuance Costs Included In Accrued Expenses Issuance Costs Included In Accrued Expenses Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Earnings Per Share [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Value of share units issued as a result of the exercise of warrants. Partners Capital Account Warrants Exercised During Period Value Exercise of warrant for common units Avenue Venture Opportunities Fund LP Member Avenue Venture Opportunities Fund LP [Member] Avenue Venture Opportunities Fund, L.P. Schedule of deferred revenue balance Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Additional Paid in Capital Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Additional paid-in capital Common Class B [Member] Common Class B [Member] Common Class B Interest income receivable included in prepaid expenses Prepaid Interest Rent expense Operating Leases, Rent Expense Operating Leases, Rent Expense, Total Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Derivative, term of contract Derivative, Term of Contract Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Fair value of RSAs vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Earnings Per Share [Abstract] Summary of Future Minimum Operating Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Related party payable Related party payable cureent liabilities Related party payable cureent liabilities Loss Contingencies [Table] Loss Contingencies [Table] South Lake One LLC and Affiliates South Lake One L L C And Affiliates [Member] South Lake One L L C And Affiliates. Accounting Policies [Abstract] Lessee, Lease, Description [Table] Increase net of tax assets Increase net of tax assets Effect of exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC Stock Issued During Period, Shares, Conversion of Units Scenario [Axis] Concentrations of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock options Stock Options [Member] Equity Option [Member] Agreement termination negotiation period. Agreement Termination Negotiation Period Agreement termination negotiation period Cash, cash equivalents, restricted cash equivalents and marketable securities Cash, Cash Equivalents, Restricted Cash Equivalents and Marketable Securities Cash, Cash Equivalents, Restricted Cash Equivalents and Marketable Securities Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., basic Schedule of Cash and Cash Equivalents [Table] Commitments and Contingencies Commitments and contingencies (Note 10) Related Party Related Party, Type [Axis] Beneficially number of shares held Excess Stock, Shares Outstanding Issued classified warrants Adjustments to Additional Paid in Capital, Warrant Issued Weighted Average Remaining Contractual Term, Canceled and replaced with stock options (in years) Share based Compensation Arrangement By Share based Payment Award Options Canceled And Replaced Weighted Average Remaining Contractual Term Share based Compensation Arrangement By Share based Payment Award Options Canceled And Replaced Weighted Average Remaining Contractual Term Measurement Input Type Measurement Input Type [Axis] Statistical Measurement Statistical Measurement [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Operating activities, net Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Operating activities, net Schedule of Amounts Charged for Services and Rent Schedule of Related Party Transactions [Table Text Block] Proceeds from Issuance of Debt International government Government [Member] Effects of the IPO and related Organizational Transactions [Member] Effects of the IPO and related Organizational Transactions [Member] All Award Types All Award Types Document Period End Date Document Period End Date Statistical Measurement Statistical Measurement [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., diluted Profits Interests Threshold, Granted Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Grants Profits Interests Activity Threshold Grants Weighted Average Grant Date Fair Value, Forfeited Share Based Compensation Profit Interests Forfeitures Weighted Average Grant Date Fair Value Share Based Compensation Profit Interests Forfeitures Weighted Average Grant Date Fair Value. Debt Instrument, Name [Domain] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at June 30, 2022 Convertible Preferred units issued Limited Liability Company (LLC) Preferred Unit, Issued Related Party Transaction Related Party Transaction [Domain] Fair Value, Recurring Fair Value, Recurring [Member] Issuance of common stock under employee stock purchase plan Proceeds from Issuance of common stock under the employee stock purchase plan Proceeds from Issuance of common stock under the employee stock purchase plan Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term. Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Nonvested at June 30, 2022 (in years) Schedule of Future Principal Payments for the Company's Debt Schedule of Maturities of Long-Term Debt [Table Text Block] U.S. Treasuries US Treasury Securities [Member] U.S. Treasuries U.S. Treasuries [Member] US Treasuries [Member] US Treasuries [Member] Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value. Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value Aggregate Intrinsic Value, Nonvested at June 30, 2022 (in thousands) Non-controlling interest Equity, Attributable to Noncontrolling Interest Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Total Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Convertible Preferred units outstanding Limited Liability Company (LLC) Preferred Unit, Outstanding Warrants and Rights Note Disclosure [Abstract] Credit Facility [Domain] Equity [Abstract] Less: Imputed interest Less: Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Granted, number of shares Granted, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Paired Interests Paired Interest [Member] Paired Interests [Member] Paired Interests [Member] Revision of Prior Period [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Granted as replacement of Profits Interests, Weighted-Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants As Replacement Of Profits Interests In Period Weighted Average Grant Date Fair Value Share based compensation arrangement by share based payment award equity instruments other than options grants as replacement of profits interests in period weighted average grant date fair value. Equity Components Equity Components [Axis] Weighted Average Remaining Contractual Term, Granted (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Weighted Average Remaining Contractual Term. Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Weighted Average Remaining Contractual Term Profits Interests Member Units [Member] Stockholders' equity / members' deficit: Members' Equity [Abstract] Accrued interest Accrued interest Market capitalization amount Capitalization, Long-Term Debt and Equity Capitalization, Long-Term Debt and Equity, Total Vested, Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Local Phone Number Local Phone Number Deferred financing costs included in prepaid expenses Deferred Financing Costs Included In Prepaid Expenses Deferred financing costs included in prepaid expenses. Sale of Stock Sale of Stock [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Exercisable at June 30, 2022 Profits Interests Threshold, Vested Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Vested Share based compensation arrangement by share based payment award profits interests activity threshold vested. Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Forfeiture of restricted stock awards, shares Sales Agreement Sales Agreement [Member] Sales Agreement [Member] Aequanimitas Limited Aequanimitas Limited [Member] Aequanimitas Limited Statement of Cash Flows [Abstract] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Loan and Security Agreement [Member] Loan And Security Agreement [Member] Loan and Security Agreement. Paycheck Protection Program Paycheck Protection Program [Member] Paycheck Protection Program Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated other comprehensive loss Comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Common stock par value Common Stock, Par or Stated Value Per Share Accrued professional fees Accrued Professional Fees Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Debt Instrument, Interest Rate, Stated Percentage Interest Rate Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Recognized over a weighted-average period Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Maximum Maximum [Member] Maximum Convertible Preferred units authorized Limited Liability Company (LLC) Preferred Unit, Authorized Temporary Equity, Shares Outstanding Temporary Equity, Beginning Balance (in units) Temporary Equity, Ending Balance (in units) Related Party Transaction Related Party Transaction [Axis] Organization and Nature of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Related Party Transaction Income Expenses From Transactions With Related Party Related Party Transaction Income Expenses From Transactions With Related Party Related party charges Level 3 Fair Value, Inputs, Level 3 [Member] APIC, Share-Based Payment Arrangement, Increase for Cost Recognition APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation Exercise of warrant for common units, Shares Exercise of warrant for common units, Shares Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Short-Term Debt, Type [Domain] Ownership [Domain] Preferred Units, Class Preferred Units, Class [Domain] Change in estimated fair value of preferred unit warrant Change in fair value of preferred unit warrant liability Fair Value Adjustment of Warrants Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash, cash equivalents and restricted cash equivalents Number of Options, Canceled and replaced with stock options Number of Options, Canceled and replaced Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Replaced In Period Share based compensation arrangement by share based payment award options canceled and replaced in period. General and Administrative Expense General and Administrative Expense [Member] General and Administrative Cash, equivalents and restricted cash equivalents [Member] Cash, cash equivalents and restricted cash equivalents [Member] Cash, cash equivalents and restricted cash equivalents [Member] Weighted Average Remaining Contractual Term, Granted as replacement awards (in years) Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards Weighted Average Remaining Contractual Term Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards Weighted Average Remaining Contractual Term. Number of options, Forfeited Number of options, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Accrued Liabilities Total accrued expenses and other current liabilities Paired Interest Paired Interest [Member] Paired Interest Restricted Stock Awards Restricted Stock Awards [Member] Restricted stock awards. Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] City Area Code City Area Code Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Capital Units by Class [Axis] Document Information [Line Items] Accrued preclinical and clinical trial costs 1 Accrued preclinical and clinical trial costs 1 Accrued preclinical and clinical trial costs Common Stock, Voting Rights Common stock, voting rights Secondary Sales Transactions Secondary Sales Transactions [Member] Secondary sales transactions. General and administrative General and Administrative Expense General and Administrative Expense, Total Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted-average share outstanding basic Weighted Average Grant Date Fair Value, Balance at September 30, 2021 Weighted Average Grant Date Fair Value, Balance at December 31, 2020 Share Based Compensation Profit Interests Weighted Average Grant Date Fair Value Share Based Compensation Profit Interests Weighted Average Grant Date Fair Value. Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Lessee, Operating Lease, Description ICL ICL In Cube Labs L L C [Member] InCube Labs, LLC Summary of Restricted Stock Unit and Award Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Loss on extinguishment of debt Loss on extinguishment of debt Loss from debt extinguishment Gain (Loss) on Extinguishment of Debt Gain (Loss) on Extinguishment of Debt, Total Statement [Table] Statement [Table] Summary of Stock Options and Options for Common Units Activity Summary Of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule Of Related Party Transactions By Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Document Fiscal Period Focus Document Fiscal Period Focus Total undiscounted future minimum lease payments Total undiscounted future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Future minimum lease payments Related Party Transactions Related Party Transactions Disclosure [Text Block] 2023 (remaining six months) 2023 (totaled) Lessee, Operating Lease, Liability, to be Paid, Year Two Statement [Line Items] Statement [Line Items] Avenue Venture Opportunity Fund L.P Member Avenue Venture Opportunity Fund L P [Member] Avenue venture opportunity fund L.P member. Exchanged paired interests for the Company's Class A common stock Anti-dilutive securities excluded from computation of diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Contract assets Contract with Customer, Asset, after Allowance for Credit Loss Contract with Customer, Asset, after Allowance for Credit Loss, Total Other Other Accrued Liabilities Subsequent Event [Line Items] Preferred unit warrant liability Warrant [Member] Activity subsequent to the IPO and related Organizational Transactions [Member] Activity subsequent to the IPO and related Organizational Transactions [Member] Takeda Agreement [Member] Takeda Agreement [Member] Takeda Agreement [Member] Asset Class [Domain] Common Stock [Member] Common [Member] Common Unit Debt Instrument [Line Items] Debt Instrument [Line Items] Series E Preferred Units [Member] Series E preferred units. Series E Preferred Units Operating Lease, Lease Income [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash and Cash Equivalents, at Carrying Value Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of Components of Equity-based Compensation Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable at June 30, 2022 (in thousands) Net accretion and amortization of investments in marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Prepaid Expense, Current, Total Prepaid Expense, Current Prepaid expenses and other current assets Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Debt Securities, Available-for-Sale Proceeds from Sale of Debt Securities, Available-for-Sale Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease), Total Change in estimated fair value Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards In Period Gross Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards In Period Gross. Number of Options, Granted as replacement awards Cover [Abstract] Effects of Organizational Transactions shares. Effects of Organizational Transactions Shares Vesting [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Stock-based compensation expense Depletion Depletion, Total Cash paid for income taxes Income Taxes Paid, Net Income Taxes Paid, Net, Total Settlement of preferred unit warrant liability Settlement of preferred unit warrant liability. Settlement of Preferred Unit Warrant Liability Sale of Stock Sale of Stock [Domain] Granted, Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Security Exchange Name Security Exchange Name Balance at beginning of period Balance at end of period Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs Schedule of Reconciliation of cash, cash equivalents and restricted cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Preferred stock issued Preferred Stock, Shares Issued Preferred Stock, Shares Issued, Total Preferred stock authorized Units Authorized Preferred Stock, Shares Authorized Summary of consolidated balance sheets and statements of cash flow related to leases Condensed Cash Flow Statement [Table Text Block] Contributions withheld from employees Accrued Payroll Taxes Fair Value (in thousands) Derivative Liability, Subject to Master Netting Arrangement, before Offset Derivative Liability, Fair Value, Gross Liability, Total Right- Of- use asset obtained in exchange for operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Weighted Average Grant Date Fair Value, Vested Share Based Compensation Profit Interests Vested Weighted Average Grant Date Fair Value Share Based Compensation Profit Interests Vested Weighted Average Grant Date Fair Value Issuance of Series E Preferred units, Shares Issuance of Series E Preferred units, Shares Rani LLC [Member] Rani LLC. Rani L L C [Member] Weighted Average Exercise Price per Share, Forfeited Weighted Average Exercise Price per Share, Canceled and replaced with stock options Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Financial Instrument [Axis] Warrants exercisable period Warrants and Rights Outstanding, Term Class of Warrant or Right [Table] Entity Emerging Growth Company Entity Emerging Growth Company Number of Profit Interests, Balance at September 30, 2021 Number of Profit Interests, Balance at December 31, 2020 Share Based Compensation Number Of Profits Interests Outstanding Number Share Based Compensation Number Of Profits Interests Outstanding Number. Amendment Flag Amendment Flag Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] IPO [Member] IPO [Member] IPO Accounting Standards Update [Domain] Leases [Abstract] Payroll and related Accrued Salaries Entity File Number Securities Act File Number Partners' Capital Partners' Capital, Total Beginning Balance Ending Balance Agreement termination period Agreement Termination Period Agreement termination period Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted Average Vesting Period Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted Average Vesting Period Weighted average vesting term Long-term debt Long-Term Debt, Excluding Current Maturities Long-Term Debt, Excluding Current Maturities, Total Cash, cash equivalents and restricted cash equivalents, Beginning Balance Cash, cash equivalents and restricted cash equivalents, end of period Cash, cash equivalents and restricted cash equivalents, end of period Cash, cash equivalents and restricted cash equivalents, end of period Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Share-Based Payment Arrangement [Abstract] Profits Interests Threshold, Balance at September 30, 2021 Profits Interests Threshold, Balance at December 31, 2020 Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Profits interests activity threshold Accounts payable Accounts Payable, Current Accounts Payable, Current, Total Debt Instrument [Axis] Cash Equivalents, Restricted Cash Equivalents and Marketable Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Outstanding, Weighted-Average Grant Date Fair Value Outstanding, Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Total operating expenses Operating Expenses Long-Term Debt, Maturity, Year One 2024 Issuance of warrants Issuance of warrants Cash Equivalents, Restricted Cash Equivalents and Marketable Securities Cash Equivalents Restricted Cash Equivalents and Marketable Securities Policy Text Block Cash Equivalents Restricted Cash Equivalents and Marketable Securities Policy Text Block Adjustments to Additional Paid in Capital, Other Issuance of common stock under employee equity plans, net of shares withheld for tax settlement, amount Accrued Liabilities and Other Liabilities Accrued expenses and other current liabilities Schedule Of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Preferred stock, $0.0001 par value - 20,000 shares authorized; none issued and outstanding as of June 30, 2023 and December 31, 2022 Carrying Value Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Ending Balance Entity Small Business Entity Small Business Term of Loan security agreement Description Term of Loan security agreement Description Entity Shell Company Entity Shell Company Aggregate Intrinsic Value, Granted as replacement awards (in thousands) Share-based Compensation Arrangement by Share-based Payment Award Options Granted As Replacement Awards in Period Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award Options Granted As Replacement Awards in Period Intrinsic Value. Sale of common units Sale of Stock, Number of Shares Issued in Transaction Warrants Warrants [Text Block] The entire disclosure of warrants. Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant exercise price Cash paid for amounts included in lease liabilities: Payments for Operating Activities [Abstract] Class of Warrant or Right Class of Warrant or Right [Domain] Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Issuance of common stock under employee equity plans, net of shares withheld for tax settlement , shares Net Loss Per Share Earnings Per Share [Text Block] Warrants Warrants and Rights Subject to Mandatory Redemption [Member] Commercial paper Commercial Paper [Member] Entity Address, Address Line One Entity Address, Address Line One Evaluation Agreements Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block] Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Antidilutive Securities Antidilutive Securities [Axis] Measurement Input, Price Volatility Measurement Input, Price Volatility [Member] Interest Rate On Loan Interest Rate During Period Debt Instrument, Interest Rate During Period Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance Weighted Average Exercise Price per Share, Nonvested at June 30, 2022 Subsequent Event Type Subsequent Event Type [Domain] Partners' Capital Account, Units Ending Balance (in units) Beginning Balance (in units) Restricted Cash Equivalents Restricted Cash Equivalents, Fair Value Disclosure Restricted Cash Equivalents, Fair Value Disclosure Income Statement Location Income Statement Location [Axis] Net unrealized(loss) gain on marketable securities Net unrealized gain on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Long-Term Debt, Maturity, Year Three 2026 Number Of Tranches Number Of Tranches Amount payable for evaluation services Amount Payable For Evaluation Services Amount payable for services. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary of significant accounting policies. Net loss Net loss Net loss and comprehensive loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The entire disclosure for evaluation agreements. Evaluation Agreements [Text Block] Evaluation Agreements Level 2 Fair Value, Inputs, Level 2 [Member] Registration Rights Agreement [Member] Registration Rights Agreement [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Long-Term Debt, Gross, Total Total long-term debt Long-Term Debt, Gross Title of 12(b) Security Title of 12(b) Security Previously Reported [Member] Previously Reported [Member] Convertible preferred units Temporary Equity, Carrying Amount, Attributable to Parent Temporary Equity, Beginning Balance Temporary Equity, Ending Balance Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest General Partner Ownership Interest Accumulated Other Comprehensive Loss Member Accumulated Other Comprehensive Loss Member Accumulated Other Comprehensive Loss Member Accounting Standards Update [Axis] Prepaid Expenses and Other Current Assets [Member] Prepaid Expenses and Other Current Assets [Member] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Long-Term Line of Credit, Total Long-Term Line of Credit Loan Facility Subsequent Event [Table] Issuance costs deducted from long-term debt proceeds Issuance Costs Deducted From Long-Term Debt Proceeds Issuance Costs Deducted From Long-Term Debt Proceeds Cancelled Number of Profit Interests, Canceled and replaced with restricted stock awards Share Based Compensation Number Of Profits Interests Canceled And Replaced With Restricted Stock Awards Share Based Compensation Number Of Profits Interests Canceled And Replaced With Restricted Stock Awards. Sales price and fair value of common units, difference Sales Price And Fair Value Of Common Units Difference Amount Sales price and fair value of common units, difference amount. Gross Unrealized loss Gross Unrealized loss Debt Securities, Available-for-Sale, Unrealized Loss Cash and Cash Equivalents Cash and Cash Equivalents [Axis] Common units outstanding Common stock, shares outstanding Common Unit, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Exercisable at June 30, 2022 (in years) Beginning Balance (shares) Ending Balance (shares) Common stock shares outstanding Common Stock, Shares, Outstanding Common units holders Common Unit Issued Common Unit, Issued Equity-Based Compensation Share-Based Payment Arrangement [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited, Weighted-Average Grant Date Fair Value Outstanding Capital Class A Unit [Member] Outstanding Capital Class A Unit [Member] Supplemental disclosures of cash flow information Supplemental Cash Flow Elements [Abstract] Operating lease discount rate Lessee, Operating Lease, Discount Rate Income Statement Location Income Statement Location [Domain] Weighted Average Exercise Price per Share, Unit Grants Weighted Average Exercise Price per Share, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Document Type Document Type Ownership [Axis] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Common Class C [Member] Common Class C [Member] Document Quarterly Report Document Quarterly Report Share-Based Payment Arrangement [Member] Equity-Based Compensation Number of Profit Interests Granted Share Based Compensation Number Of Profits Interests Grants In Period Gross Share Based Compensation Number Of Profits Interests Grants In Period Gross. Marketable securities Marketable Securities Marketable Securities, Total Warrants and Rights Outstanding Fair value totaling Fair value measurement probability of exit events Fair Value Measurement Probability Of Exit Events Fair value measurement probability of exit events. Loan Restructuring Modification Name [Axis] Net Asset Value Per Share Net Asset Value Per Share, Ending Balance Net Asset Value Per Share, Beginning Balance Forfeited, Number of Shares Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Entity Filer Category Entity Filer Category Supplemental disclosures of non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Total cash, cash equivalents and restricted cash equivalents Restricted cash equivalents, end of period Restricted Cash and Cash Equivalents Restricted Cash and Cash Equivalents, Total Balance Sheet Location [Domain] Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Accrued Liabilities, Total Accrued expenses and other current liabilities Non-controlling interest adjustment for purchase of newly issued Class A units of Rani LLC with proceeds from the IPO Net loss Non-controlling interest adjustment for purchase of newly issued Class A units of Rani LLC with proceeds from the IPO Net loss Tax Receivable Agreement Tax Receivable Agreement, Policy [Policy Text Block] Tax Receivable Agreement, Policy [Policy Text Block] Purchases of marketable securities Purchases of marketable securities Payments to Acquire Marketable Securities Asset Class [Axis] Capital Expenditures Incurred but Not yet Paid Property and equipment purchases included in accounts payable and accrued expenses and other current liabilities Total liabilities Liabilities Gross unrealized Gains Debt Securities, Available-for-Sale, Unrealized Gain Interest Receivable Interest income receivable Issuance of common stock under employee equity plans, net of repurchased shares for tax withholdings related to net settlement of employee equity awards, amount Issuance of common stock under employee equity plans, net of repurchased shares for tax withholdings related to net settlement of employee equity awards, amount Total stockholders' equity attributable to Rani Therapeutics Holdings, Inc. Equity, Attributable to Parent Stockholders' Equity Attributable to Parent, Ending Balance Stockholders' Equity Attributable to Parent, Beginning Balance Accrued Liabilities [Abstract] Summary of Profits Interests Activity Schedule Of Share Based Compensation Profits Interests Activity Table [Text Block] Tabular disclosure for profits interests activity. Consolidated Entities Consolidated Entities [Axis] Net loss Net loss attributable to Rani Therapeutics Holdings, Inc. Net loss attributable to Rani Therapeutics Holdings, Inc. Net Income (Loss) Weighted Average Grant Date Fair Value, Canceled and replaced with restricted stock awards Share Based Compensation Profit Interests Canceled And Replaced With Restricted Stock Awards Weighted Average Grant Date Fair Value Share Based Compensation Profit Interests Canceled And Replaced With Restricted Stock Awards Weighted Average Grant Date Fair Value. Other income (expense), net Nonoperating Income (Expense) [Abstract] Interest expense and other, net Interest Expense Interest Expense, Total Long-Term Debt, Unclassified [Abstract] Continuing LLC Owners [Member] Continuing LLC Owners Number of Profit Interests Forfeited Share Based Compensation Number Of Profits Interests Forfeitures Share Based Compensation Number Of Profits Interests Forfeitures. Restricted Cash Equivalents, Current Restricted cash equivalents Cash and Cash Equivalents Cash and Cash Equivalents [Domain] Corporate debt securities Corporate Debt Securities [Member] Statement of Financial Position [Abstract] Basis of Presentation and Accounting Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted-average share outstanding diluted Credit Facility [Axis] Non-cash operating lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Two Thousand And Twenty One Employee Stock Purchase Plan [Member] Two Thousand And Twenty One Employee Stock Purchase Plan [Member] 2021 Employee Stock Purchase Plan Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Percent, Total Novartis Agreement [Member] Novartis Agreement [Member] Novartis Agreement [Member] Aggregate Intrinsic Value, Granted (in thousands) Amount of accumulated difference between fair value of underlying shares on dates of grant and grant price on options granted (or share units converted) into shares. Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Intrinsic Value Service agreement term. Service Agreement Term Service agreement term Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Total Weighted average remaining lease term Service agreement remaining term Operating Lease, Weighted Average Remaining Lease Term Use of Estimates Use of Estimates, Policy [Policy Text Block] Income Tax Disclosure [Text Block] Income Taxes Restricted Cash Equivalents [Member] Restricted Cash Equivalents [Member] Interest and Other Income Interest income and other, net Weighted Average Exercise Price per Share, Outstanding, Beginning balance Weighted Average Exercise Price per Share, Outstanding, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock options, outstanding, weighted average exercise price International goverment Debt Security, Government, Non-US [Member] Exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC Exchanges Of Paired Interests And Non-Corresponding Class A Units Exchanges Of Paired Interests And Non-Corresponding Class A Units Schedule of Computation of Basic and Diluted Net Loss Per Class A Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Disaggregation of Revenue [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value Disclosures [Abstract] Aggregate desired patent acquisition Aggregate desired patent acquisition Comprehensive loss Comprehensive loss Comprehensive loss attributable to Rani Therapeutics Holdings, Inc. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Measurement Frequency Measurement Frequency [Domain] Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Revision of Prior Period [Domain] Members' Deficit [Member] Members' Deficit. Members' Deficit [Member] Settlement of Series E warrants Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements Vested, Number of Shares Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Issuance of Class A common stock in connection with the IPO, net of issuance costs $10,686, shares Stock Issued During Period, Shares, New Issues Issuance of common stock, shares Operating lease expenses Operating Lease, Expense Other Comprehensive Income (Loss), Tax [Abstract] Other comprehensive loss Class of Warrant or Right Class of Warrant or Right [Axis] Proceeds from Sale and Maturity of Marketable Securities Proceeds from maturities of marketable securities Income Tax Disclosure [Abstract]